edetic acid has been researched along with pulmicort in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andersson, SE; Ekström, GM | 1 |
| Cherian, LM; Cooksley, C; Paramasivan, S; Psaltis, AJ; Ramezanpour, M; Richter, K; Vreugde, S; Wormald, PJ | 1 |
1 review(s) available for edetic acid and pulmicort
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for edetic acid and pulmicort
| Article | Year |
|---|---|
Plasma exudation, hyperaemia, and epithelial permeability in rats with oxazolone-induced colitis: modulatory effects of budesonide.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Budesonide; Colitis; Colon; Disease Models, Animal; Edetic Acid; Endothelium; Epithelium; Female; Glucocorticoids; Humans; Intestine, Small; Oxazolone; Permeability; Rats | 2000 |
Effect of commercial nasal steroid preparation on bacterial growth.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biofilms; Budesonide; Cell Line; Cell Survival; Edetic Acid; Excipients; Glucocorticoids; Humans; Microbial Sensitivity Tests; Nasal Mucosa; Staphylococcus aureus | 2019 |